Actively Recruiting
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
Led by Fudan University · Updated on 2024-11-26
50
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy of low-dose vitamin C plus herbal medicine on improving the quality of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel chemotherapy.
CONDITIONS
Official Title
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to understand and willing to sign informed consent
- Age 18 to 80 years
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Histologically or cytologically confirmed metastatic pancreatic adenocarcinoma
- Adequate organ function based on laboratory tests
- At least one measurable lesion according to RECIST criteria
- Hemoglobin level of 8 g/dL or higher
- Expected survival of at least 3 months
- Women of childbearing potential and men must agree to use adequate contraception during the study
You will not qualify if you...
- Received anti-tumor treatment for other cancers in the last 2 years
- Previously received any anti-tumor therapy for pancreatic cancer
- Diagnosis of non-adenocarcinoma pancreatic cancer
- Inflammation of the digestive tract such as pancreatitis, cholecystitis, or cholangitis
- Pregnant or nursing women
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Severe uncontrolled diseases including infections, diabetes, hypertension, or heart conditions (Class III or IV heart failure, recent myocardial infarction, unstable arrhythmia or angina, recent cerebral infarction)
- Kidney failure or dialysis
- Allergic reactions to gemcitabine, nab-paclitaxel, or related agents
- Other serious illnesses that may affect safety or study compliance
- Unwilling or unable to follow study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Cancer Center
Shanghai, China, 200032
Actively Recruiting
Research Team
H
Huanyu Xia, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here